Biomaterials Companies and Market Analysis
The biomaterials market comprises all kinds of biomaterials such as ceramics, composites, biodegradable, orthopaedic materials, etc. The market is anticipated to reach $130.57 billion by 2020, at a progress of CGAR of 16% from 2015-2020 prediction. Biomaterials have applications in the field of oncology i.e, the study of prevention, treatment of cancer. Few biomaterials companies that are comprised in the global biomaterials market are Zimmer Biomet Holdings, Inc. (U.S.), Carpenter Technology Corporation (U.S.), Covalon Technologies Ltd. (Canada), Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Collagen Matrix, Inc. (U.S.).
Related Conference of Biomaterials Companies and Market Analysis
7th International Conference on Nanomedicine and Nanotechnology
11th Global Conference on Smart Materials and Nanotechnology
Biomaterials Companies and Market Analysis Conference Speakers
Recommended Sessions
- Bio-based Materials and Sustainability
- 3D Printing of Biomaterials
- Advanced Biomaterials
- Bio-Nanomaterials
- Biodegradable Biomaterials
- Biofunctional Materials
- Bioinspired Materials
- Biomaterials
- Biomaterials and Nanotechnology
- Biomaterials Applications
- Biomaterials Companies and Market Analysis
- Biomaterials in Drug Delivery Systems
- Biophotonics and Biomedical Optics
- Dental Biomaterials
- Polymer Biomaterials
- Properties of Biomaterials
- Tissue Engineering and Regenerative Medicine
Related Journals
Are you interested in
- 2D Materials Beyond Graphene - Euro Nanomat- 2024 (UK)
- Advances in Nanomaterials Synthesis and Characterization - Nanochemistry 2024 (USA)
- Bioinspired Nanotechnology - Euro Nanomat- 2024 (UK)
- Emerging Trends in Nano Chemistry and Nano Medicine - Nanochemistry 2024 (USA)
- Green Nanotechnology: Sustainable Approaches in Nano Medicine - Nanochemistry 2024 (USA)
- Immunotherapy - Euro Nanomat- 2024 (UK)
- Nano-Bio Interfaces: Interaction and Compatibility - Nanochemistry 2024 (USA)
- Nanocarriers for Gene Delivery and Gene Editing - Nanochemistry 2024 (USA)
- Nanodevices for Point-of-Care Diagnostics and Wearable Health Monitoring - Nanochemistry 2024 (USA)
- Nanomaterials for Neural Interfaces and Brain Therapeutics - Nanochemistry 2024 (USA)
- Nanomedicine for Cancer Therapy: Challenges and Opportunities - Nanochemistry 2024 (USA)
- Nanomedicine for Targeted Therapies - Euro Nanomat- 2024 (UK)
- Nanoparticles for Drug Delivery: Targeting and Controlled Release - Nanochemistry 2024 (USA)
- Nanoparticles for Photothermal and Photodynamic Therapy - Nanochemistry 2024 (USA)
- Nanophotonics and Plasmonics in Biomedical Applications - Nanochemistry 2024 (USA)
- Nanoscale Imaging and Spectroscopy in Biomedical Research - Nanochemistry 2024 (USA)
- Nanoscale Sensors and Diagnostics for Early Disease Detection - Nanochemistry 2024 (USA)
- Nanosensors and Diagnostics - Euro Nanomat- 2024 (UK)
- Nanotechnology and Artificial Intelligence (AI) - Euro Nanomat- 2024 (UK)
- Nanotechnology for Environmental Remediation - Euro Nanomat- 2024 (UK)
- Nanotechnology for Infectious Disease Diagnosis and Treatment - Nanochemistry 2024 (USA)
- Nanotechnology in Agriculture - Euro Nanomat- 2024 (UK)
- Nanotechnology in Space Exploration - Euro Nanomat- 2024 (UK)
- Nanotechnology in Stem Cell Engineering and Therapy - Nanochemistry 2024 (USA)
- Nanotechnology in Tissue Engineering and Regenerative Medicine - Nanochemistry 2024 (USA)
- Nanotechnology in Vaccine Development and Immunotherapy - Nanochemistry 2024 (USA)
- Nanotechnology in Wearable and Flexible Electronics - Euro Nanomat- 2024 (UK)
- Nanotoxicology and Safety Assessment of Nanomedicine - Nanochemistry 2024 (USA)
- Nanozymes: Enzyme-Mimicking Nanomaterials in Medicine - Nanochemistry 2024 (USA)
- Quantum Dots and Nanocrystals: Applications in Biomedicine - Nanochemistry 2024 (USA)
- Quantum Nanoscience - Euro Nanomat- 2024 (UK)